Clinical Trials Sponsored by Cardiome Pharma

Total 8404 results

UCB Pharma

Completed

Evaluation of Safety of Levocetirizine in Routine Clinical Practice-non- Interventional Study

Rhinitis Allergic, Persistent

United States
UCB Pharma

Withdrawn

A Trial Evaluating Safety of Chronic Therapy With Certolizumab Pegol in Crohn's Disease

Crohn's Disease
UCB Pharma

Withdrawn

A Study to Evaluate the Efficacy and Safety of Seletracetam in Adult Patients With Refractory Partial Onset Seizures

Epilepsies, Partial
UCB Pharma

Completed

Cross Sectional Study to Evaluate the Acceptability of Oral Solution of Levetiracetam

Epilepsy

Spain
AM-Pharma

Terminated

A Study in Sepsis Patients With Renal Failure

Sepsis | Bacterial Infections and Mycoses

Netherlands, Belgium
UCB Pharma

Completed

The First Clinical Study to Test Safety, Blood Levels and Other Effects of CDP6038 in Healthy Males

Pharmacokinetics

Germany
Vifor Pharma

Completed

A Drug-Drug Interaction Study of Warfarin and PA21

Drug Interaction Potentiation

United States
Clavis Pharma

Completed

A Study of CP-4126 in Patients With Advanced Pancreatic Cancer

Advanced Adenocarcinoma of Pancreas

Norway, Belgium
Vifor Pharma

Completed

A Drug-Drug Interaction Study of Digoxin and PA21

Drug Interaction Potentiation

United States
Otic Pharma

Completed

Efficacy and Safety of Once-Daily Ciprodexa Otic Foam Compared to Twice-daily Ciprodex Ear Drops in Acute Otitis Externa (Ciprodexa Foam)

Otorhinolaryngologic Diseases | Ear Diseases | Otitis Externa | Otitis

Israel
Vifor Pharma

Completed

A Drug-Drug Interaction Study of Furosemide and PA21

Healthy

United States
UCB Pharma

Completed

Pharmacokinetic (PK)/Pharmacodynamic (PD), Study of Single-dose Subcutaneous CDP6038 in Healthy Japanese Male Subjects

Healthy Volunteers

United Kingdom
UCB Pharma

Completed

Study of Epratuzumab in Serologically-positive Systemic Lupus Erythematosus (SLE) Patients With Active Disease

Systemic Lupus Erythematosus

United States, Poland, Spain, Belgium, India, Ukraine, Brazil, United Kingdom, Hungary, Lithuania, Hong Kong
Closter Pharma

Unknown

Real Life Experience of the Use of Isomers as ALENCAL (Levamlodipine) for Evaluation of Efficacy, Safety and Tolerability in the Management of Cardiovascular Disease in Colombian Patients (XPRES)

Hypertension

Colombia
UCB Pharma

Completed

Comparison Bioequivalence Study: Pre-filled Syringe (Reference) Versus Auto-injection Device (Test)

Healthy

France
Closter Pharma

Unknown

Efficacy, Safety and Adherence of Patients Infected With Hepatitis C Virus in Retreat With INFERGEN (Interferon Alfacon1) (OBSERVER)

Hepatitis C
PLx Pharma

Completed

Food-Effect Pharmacokinetic Study of PL2200

Healthy

United States
Zealand Pharma

Completed

Healthy Normal Single Ascending Dose and Crohn's Patient Multiple Ascending Dose

Inflammatory Bowel Disease

United States
Vifor Pharma

Terminated

Ferinject® in Patient With Thrombocytosis Secondary to Inflammatory Bowel Disease (IBD)

Thrombocytosis | Iron-Deficiency Anemia

Austria
Otic Pharma

Completed

Safety and Efficacy Study of Foam Otic Cipro Compared to a Standard Solution ( Ciloxan - Alcon Labs ) to Treat Acute Otitis Externa

Otorhinolaryngologic Diseases | Ear Diseases | Otitis Externa | Otitis

Israel
Advanz Pharma

Completed

A Phase III Superiority Study of Vernakalant vs Amiodarone in Subjects With Recent Onset Atrial Fibrillation (AVRO)

Atrial Fibrillation

Australia, Netherlands, Canada, France, Germany, Lithuania, Ukraine, Czech Republic, Denmark, Estonia, Finland, Latvia, Poland, Serbia, Slovakia, Sweden
Omega Pharma

Completed

Randomized Controlled Trial Comparing Efficacy and Tolerance of Four Pediculicides

Headlice Infections

India
LEO Pharma

Terminated

Efficacy and Safety of 3 Doses of HL10 Given at Fixed Time Intervals Compared to Standard Therapy

Acute Respiratory Distress Syndrome | Acute Lung Injury

Denmark, Belgium, Austria, Canada, Finland, France, Germany, Netherlands, Norway, Spain, Sweden, United Kingdom
NeuTec Pharma

Completed

Preliminary Study of Mycograb and Docetaxel in Advanced Breast Cancer

Cancer of the Breast

Poland, Serbia
LEO Pharma

Completed

LEO19123 Cream in the Treatment of Atopic Dermatitis

Atopic Dermatitis

United Kingdom, Finland, Canada, Denmark
UCB Pharma

Completed

The COMACS Study: A Comparison of Methylphenidates in an Analog Classroom Setting

Attention Deficit Hyperactivity Disorder
UCB Pharma

Completed

Testing the Efficacy of Different Dosages of Lercanidipine to Reduce Hypertensive Blood Pressure in Normal Weight and Obese Patients

Hypertension
UCB Pharma

Completed

An Open-Label Interaction Study to Look at the Effects of Brivaracetam on Phenytoin When Taken Together in 15 Adult Patients With Epilepsy.

Epilepsy

United States
LEO Pharma

Completed

Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Ointment in Patients With Psoriasis Vulgaris

Psoriasis Vulgaris

China
LEO Pharma

Terminated

Seocalcitol Versus Placebo in the Adjuvant Treatment of Hepatocellular Carcinoma

Liver Neoplasms

Canada, France, Italy, Spain, United Kingdom
NeuTec Pharma

Completed

Aurograb and Vancomycin in MRSA Infection

Staphylococcal Infections

United Kingdom
Zeneus Pharma

Unknown

Myocet, Docetaxel & Trastuzumab as 1st Line Treatment of Patients With HER-2/Neu Positive Metastatic Breast Cancer

Metastatic Breast Cancer

Italy
Zeneus Pharma

Unknown

Open Label, Single Arm, Phase II Study Using R-COMP in Elderly Patients With Aggressive NHL.

Aggressive Non-Hodgkin's Lymphoma in the Elderly.

France, Germany, Spain, United Kingdom, Italy
LEO Pharma

Not yet recruiting

A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis (TRAPEDS 2)

Atopic Dermatitis
Cryonove Pharma

Not yet recruiting

Evaluation of the Tolerance (Main Objective) and Performance of Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Brown Spots (Solar and Senile Lentigines, Post-inflammatory Hyperpigmentation) on the Face (CS5_10B)

Lentigo | Solar Lentigo | Post Inflammatory Hyperpigmentation
Pharma Nueva

Not yet recruiting

Bioequivalence Study of Generic Racecadotril 100 mg Capsules Under Fasting Conditions

Healthy Vollunteer
Longbio Pharma

Recruiting

A Study of Single and Multiple Doses of LP-005 in Healthy Adult Participants

Paroxysmal Nocturnal Hemoglobinuria (PNH)

China
LEO Pharma

Recruiting

A Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Delgocitinib Cream in Chinese Adults and Adolescents With Moderate to Severe Chronic Hand Eczema

Chronic Hand Eczema

China
Getz Pharma

Not yet recruiting

Medical Stone Expulsive Therapy for Acutely Obstructed Ureteric Calculi

Ureteric Stone of Lower Third of Ureter
LEO Pharma

Recruiting

A 32-week Trial to Evaluate the Efficacy and Safety of Tralokinumab in Subjects With Moderate-to-severe Atopic Hand Eczema Who Are Candidates for Systemic Therapy (ADHAND)

Atopic Dermatitis | Atopic Hand Eczema

United States, Canada, United Kingdom, Korea, Republic of
LEO Pharma

Recruiting

A Trial to Evaluate the Efficacy and Safety of Different Doses of LEO 138559 in Adults With Moderate-to-severe Atopic Dermatitis

Atopic Dermatitis

United States, Canada, France, Germany, Japan, Poland, United Kingdom, Czechia, Spain, Romania, Hungary
MaaT Pharma

Recruiting

Safety and Gut Microbiota Analysis of an Oral Microbiotherapy in Patients With Amyotrophic Lateral Sclerosis (IASO)

Amyotrophic Lateral Sclerosis | ALS

France
MaaT Pharma

Recruiting

Oral Pooled Fecal Microbiotherapy to Prevent Allogeneic Hematopoietic Cell Transplantation Complications (PHOEBUS Trial)

Transplant Complication

Germany, France
Initiator Pharma

Not yet recruiting

Bioavailability Study to Compare Liquid vs Two Solid Formulations of IP2015

Bioavailability
Ellipses Pharma

Recruiting

A Study of EP0031 in Patients With Advanced RET-altered Malignancies

Advanced Solid Tumor

United States, Spain, United Kingdom
Kibow Pharma

Recruiting

Rollover Extension Clinical Trial To Evaluate The Long-Term Safety And Efficacy Of KT-301 (Formerly US-APR2020) In Subjects With CKD IV Completing The US-APR2020-01 Study

Chronic Kidney Disease stage4

United States
Pherecydes Pharma

Recruiting

Phage Therapy in Prosthetic Joint Infection Due to Staphylococcus Aureus Treated With DAIR. (PhagoDAIRI)

Infection of Total Hip Joint Prosthesis | Infection of Total Knee Joint Prosthesis

France
Code Pharma

Recruiting

Phase IIa Randomized Placebo Controlled Clinical Study of Codivir in Hospitalized Patients With Moderate COVID-19

COVID-19

South Africa
Horus Pharma

Not yet recruiting

Evaluation of Neovis® Total Multi Versus Systane® Balance on Ocular Dryness Associated With Meibomian Gland Dysfunction

Dry Eye | Meibomian Gland Dysfunction
Initiator Pharma

Not yet recruiting

Study to Investigate the Pharmacodynamic Effects of IP2015 in Healthy Male Subjects Using the Intradermal Capsaicin Model

Pain

3

Subscribe